Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic Syndromes.

Xicoy, Blanca

Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic Syndromes. [electronic resource] - Leukemia & lymphoma Jun 2014 - 1300-3 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1029-2403

10.3109/10428194.2013.834532 doi


Age Factors
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic--administration & dosage
Azacitidine--administration & dosage
Female
Humans
Male
Myelodysplastic Syndromes--diagnosis
Registries
Treatment Outcome